专利检索 ap:("Hemanext Inc.") AND inv:"D'ALESSANDRO, Angelo" 第 1 页

1.

发明公开
METHODS FOR MANAGING ADVERSE EVENTS IN PATIENT POPULATIONS REQUIRING TRANSFUSION 审中-实审

公开(公告)号：EP4321215A3

公开(公告)日：2024-04-17

申请号：EP23199293.4

申请日：2017-06-22

申请人： Hemanext Inc.

发明人： D'ALESSANDRO, Angelo , CORDERO, Rafael , DUNHAM, Andrew , KEEGAN, Philip , YOSHIDA, Tatsuro

IPC分类号： A61M1/36 , A61M1/38 , A61K35/14 , A61P7/08 , A61P1/04 , A61P3/10 , A61P7/00 , A61P9/00 , A61P11/00 , A61P17/00 , A61P19/00 , A61P29/00 , A61P19/02

CPC分类号： A61M1/36 , A61M1/38 , A61K35/14 , A61P1/04 , A61P11/00 , A61P17/00 , A61P19/02 , A61P29/00 , A61P3/10 , A61P7/00 , A61P7/08 , A61P9/00

摘要： Method for transfusion medicine to reduce adverse events in transfusion patient populations based on underlying patient physiology.

2.

发明公开
METHODS FOR MANAGING ADVERSE EVENTS IN PATIENT POPULATIONS REQUIRING TRANSFUSION 审中-公开

公开(公告)号：EP4321215A2

公开(公告)日：2024-02-14

申请号：EP23199293.4

申请日：2017-06-22

申请人： Hemanext Inc.

发明人： D'ALESSANDRO, Angelo , CORDERO, Rafael , DUNHAM, Andrew , KEEGAN, Philip , YOSHIDA, Tatsuro

IPC分类号： A61P7/08

摘要： Method for transfusion medicine to reduce adverse events in transfusion patient populations based on underlying patient physiology.